This recent Applied Clinical Trials article discusses ICON's acquisition of majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, granting our company the right to acquire the remaining shares in the company by the third quarter of 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.
View ArticleRelated information
Webpage
Site & Patient Solutions
Press Release
ICON’s Acquisition of MeDiNova Research
Media Article
ICON's Site Network Acquisition Deepens EMEA Footprint - Outsourcing Pharma
Media Article
ICON Acquires Regional CRO for Patient Access in Europe and Africa - Trial Site News
Media Article